• GPR35-KLF5 Circuitry Decodes Mucosal Damage in DSS Colitis M

  2026-04-22

  This study delineates how the GPR35-KLF5 regulatory axis enables intestinal epithelial cells to detect and repair mucosal injury in ulcerative colitis, using a tryptophan metabolite-sensing mechanism. These findings refine our mechanistic understanding of epithelial repair, informing translational strategies in mouse models of inflammatory bowel disease.

• Adipose-Neural Axis in Cardiac Arrhythmia: NPY/Y1R Pathways

  2026-04-21

  Fan et al. (2024) reveal the mechanistic role of the adipose-neural axis, specifically the leptin-NPY/Y1R pathway, in driving epicardial adipose tissue-induced cardiac arrhythmias. Their stem cell-based coculture model uncovers new molecular targets for arrhythmia intervention and provides a robust platform for translational research.

• SlSLAH1-SlSTOP1 Pathway Drives Malate Exudation for Al Toler

  2026-04-21

  This study identifies the slow anion channel SlSLAH1 as a key plasma membrane malate transporter regulated by the SlSTOP1-SlSZP1 transcriptional complex, which confers aluminium tolerance in tomato. The findings clarify the molecular network controlling malate exudation under aluminium stress, offering new targets for breeding aluminium-tolerant crops.

• IBDV Exploits IRF7 Degradation via VP3 to Evade Antiviral Re

  2026-04-20

  This study reveals how infectious bursal disease virus (IBDV) suppresses the host antiviral response by targeting IRF7 for proteasomal degradation through its VP3 protein. The findings clarify a novel immune evasion strategy, with implications for antiviral research and the investigation of ubiquitin-proteasome system inhibitors.

• Cyanine 3 Tyramide: Fluorescent Dye for Biomedical Research

  2026-04-20

  Cyanine 3 Tyramide, a high-sensitivity fluorescent dye for biomedical research, drives robust signal amplification in immunohistochemistry and in situ hybridization assays. This article dissects practical workflows, advanced use-cases, and troubleshooting essentials, linking new neuroscience findings and proven protocol strategies.

• FGF/FGFR and HGF/MET Pathways Drive ESCC Growth and Resistan

  2026-04-19

  Saito et al. (2015) identified that fibroblast-derived growth factors, particularly via FGFR and MET signaling, stimulate proliferation and lapatinib resistance in esophageal squamous cell carcinoma (ESCC). Their study reveals that targeting the FGFR pathway with selective inhibitors like PD 173074 can abrogate fibroblast-mediated resistance mechanisms, highlighting a path for combinatorial treatment strategies in ESCC.

• EdU Imaging Kits (HF594): Precision Cell Proliferation Analy

  2026-04-18

  EdU Imaging Kits (HF594) empower researchers to quantify cell proliferation with unmatched sensitivity and minimal background, outperforming traditional BrdU assays. Leveraging advanced click chemistry, these kits streamline experimental workflows for fluorescence microscopy and flow cytometry, facilitating breakthrough studies in Treg cell biology and asthma research.

• Q-VD-OPh (A1901): Scenario-Driven Solutions in Apoptosis Res

  2026-04-17

  This article provides laboratory-tested, scenario-driven guidance for leveraging Q-VD-OPh (SKU A1901), a potent pan-caspase inhibitor, in apoptosis research. Drawing on peer-reviewed studies, protocol optimization, and real-world laboratory challenges, it demonstrates how this compound from APExBIO supports reproducible, cost-efficient, and high-sensitivity workflows across cell viability, proliferation, and neurodegenerative models.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-04-16

  The referenced study presents a nanoparticle-enabled strategy for systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring tumor suppressor expression and inhibiting the PI3K/Akt pathway, this approach provides a mechanistically targeted solution to a major clinical challenge.

• Cy5 TSA Fluorescence System Kit: Precision in Low-Abundance

  2026-04-15

  The Cy5 TSA Fluorescence System Kit leverages horseradish peroxidase catalyzed tyramide deposition to amplify fluorescent signals for detecting elusive molecular targets in tissue and cellular contexts. Its rapid workflow and 100-fold sensitivity boost empower researchers to profile complex developmental, regenerative, and disease processes with clarity that standard fluorescence methods cannot match.

• DAPT (GSI-IX): Strategic γ-Secretase Inhibition in Translati

  2026-04-14

  This thought-leadership article explores the mechanistic and practical impact of DAPT (GSI-IX), a potent and selective γ-secretase inhibitor, in advancing translational research. Grounded in recent evidence, including a breakthrough cell culture paradigm for corneal epithelial regeneration, the discussion bridges molecular insight, protocol design, and strategic application across neurodegeneration, oncology, and regenerative medicine. The article demonstrates how DAPT (GSI-IX) from APExBIO serves as a gold-standard tool, empowering researchers to dissect Notch signaling and amyloid precursor protein processing while highlighting best practices, competitive context, and the future of γ-secretase modulation.

• 2,2,2-Trichloroethanol: Precision in Dopaminergic Protein An

  2026-04-13

  Discover how 2,2,2-Trichloroethanol, a small molecule biochemical, advances dopaminergic protein analysis and functional neuroimaging workflows. Explore unique assay insights, reference-driven protocols, and expert guidance not found in other reviews.

• Ruxolitinib (INCB018424): Next-Gen JAK/STAT Inhibition in Tr

  2026-04-12

  This thought-leadership article provides a mechanistic and strategic guide for translational researchers leveraging Ruxolitinib (INCB018424) in advanced immuno-oncology and myeloproliferative disorder research. It integrates mechanistic insights, protocol guidance, and the latest high-dimensional immune profiling data—including evidence from combination therapy in aggressive sarcoma models. The article contextualizes APExBIO’s Ruxolitinib within the evolving landscape of JAK-STAT pathway research, addresses protocol optimization, and outlines implications for next-phase translational studies.

• Dehydroepiandrosterone (DHEA): Translational Leverage in Neu

  2026-04-12

  This article provides a thought-leadership perspective for translational researchers on Dehydroepiandrosterone (DHEA, SKU B1375), emphasizing advanced mechanistic insights, experimental best practices, and strategic guidance. It synthesizes cutting-edge evidence from recent literature—including the pivotal role of DHEA in PCOS modeling and neuroprotection—while providing protocol recommendations and a roadmap for leveraging DHEA as a competitive tool in neurodegenerative and reproductive disease research. APExBIO’s DHEA is positioned as a validated reagent addressing reproducibility and data integrity challenges, with workflow-optimized guidance for maximal translational impact.

• Applied Use of PP 2 (AG 1879): Src Kinase Inhibition Workflo

  2026-04-11

  PP 2 (AG 1879) enables precise inhibition of Src family kinases in cancer, immunology, and vascular research. This article translates bench evidence and recent mechanistic advances into actionable protocols, troubleshooting strategies, and workflow enhancements, empowering researchers to dissect complex signal transduction with confidence.

454 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page